Yahoo Web Search

Search results

  1. People also ask

  2. Spear Bio is meeting a growing market need for ultrasensitive immunoassays in smaller samples. Our platform, based on technology licensed from Harvard University, can detect single-digit counts of proteins per sample in minuscule sample volumes.

  3. Spear Bio’s 2-factor authentication detection technology allows the quantification of low abundance biomarkers at the earliest stages of a disease with exceptional precision. It can detect as low as single-digit counts of proteins per sample.

  4. Spear Bio plans to use the SPEAR technology to build a more broadly applicable protein detection platform, and will first focus on commercializing an ultra-sensitive assay that can accurately measure the levels of neutralizing antibodies (NAbs) against SARS-CoV-2.

  5. www.linkedin.com › company › spearbioSpear Bio | LinkedIn

    Spear Bio | 2,253 followers on LinkedIn. Advancing lifescience research and clinical development by enabling laboratories to perform ultrasensitive immunoassay.

  6. Nov 29, 2023 · Spear Bio has successfully launched NAB-Sure™, its first assay and commercial proof-of-concept, for ultrasensitive quantification of SARS-Cov-2 neutralizing antibodies from challenging samples...

  7. SPEAR, which stands for “Successive Proximity Extension Amplification Reaction,” enables the detection of miniscule amounts of proteins via target-binding probes that bind to different but proximal sites in a protein of interest’s structure.

  8. Aug 23, 2022 · Spear Bio plans to use the SPEAR technology to build a more broadly applicable protein detection platform, and will first focus on commercializing an ultra-sensitive assay that can...

  1. People also search for